Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be in the works from Korea’s Alteogen following a licensing deal worth ...

An evacuee from Futaba Town in Fukushima Prefecture made a comment expressing concern about the first test retrieval of fuel debris from a reactor at the Fukushima Daiichi nuclear power plant.

There has been another twist in the road for the ongoing legal battle between Seagen and Daiichi Sankyo over patent rights for antibody-drug conjugate (ADC) Enhertu. The US Patent and Trademark ...

Dai-Ichi Karkare Limited (DIKL) was set up in 1960 as a private limited company for the manufacture of speciality chemicals. The Company entered into technical collaboration with the ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Daiichi Sankyo of Basking Ridge, N.J., is the Presenting Sponsor for this year’s conference. Proceeds from the event will support research at the nonprofit Hepatitis B Foundation and Blumberg ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Dai-Ichi Karkaria Limited (DIK) was incorporated on 13 May 1960. The Company is engaged in manufacturing of specialty chemicals. The manufacturing activities of the Company are carried out from plants ...

TAL Dai-Chi Life Australia has finally finished its acquisition of Suncorp’s Australian life insurance business, announcing this afternoon that the process was complete.